Moderna Q3 Earnings
Rev: $1.31B (est $888.1M) - EPS: 38c (est loss/shr $1.09) - R&D Expenses: $583M (est $750M) - Total Operating Expenses: $1.18B (est $1.37B) - Cash & Cash Equivalents: $1.20B (est $1.37B) - Sees FY Capex: $200M (prev saw $200M To $300M; est $244.1M) - Sees FY R&D Expenses: About $2.7B (prev saw About $2.9B)
Story updates
11:57:31 AM UTC
SquawkNews
Moderna Q3 Earnings
Rev: $1.31B (est $888.1M) - EPS: 38c (est loss/shr $1.09) - R&D Expenses: $583M (est $750M) - Total Operating Expenses: $1.18B (est $1.37B) - Cash & Cash Equivalents: $1.20B (est $1.37B) - Sees FY Capex: $200M (prev saw $200M To $300M; est $244.1M) - Sees FY R&D Expenses: About $2.7B (prev saw About $2.9B)